Faiz Kermani

455 total citations
19 papers, 318 citations indexed

About

Faiz Kermani is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Biomedical Engineering. According to data from OpenAlex, Faiz Kermani has authored 19 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Public Health, Environmental and Occupational Health, 4 papers in Economics and Econometrics and 4 papers in Biomedical Engineering. Recurrent topics in Faiz Kermani's work include Biotechnology and Related Fields (9 papers), Biomedical and Engineering Education (4 papers) and Pharmaceutical Economics and Policy (4 papers). Faiz Kermani is often cited by papers focused on Biotechnology and Related Fields (9 papers), Biomedical and Engineering Education (4 papers) and Pharmaceutical Economics and Policy (4 papers). Faiz Kermani collaborates with scholars based in United States, United Kingdom and Bangladesh. Faiz Kermani's co-authors include Malcolm W. Greaves, Michihiro Hide, David M. Francis, A. KOBZA-BLACK, R.K. Winkelmann, Robert M. Barr, B. F. O’Donnell, Melanie S. Flint, Sharon A.M. Hotchkiss and Rachel M. Tribe and has published in prestigious journals such as Journal of Investigative Dermatology, Drug Discovery Today and Toxicology and Applied Pharmacology.

In The Last Decade

Faiz Kermani

15 papers receiving 297 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Faiz Kermani United States 6 218 132 126 85 60 19 318
F. Augey France 9 96 0.4× 74 0.6× 51 0.4× 135 1.6× 102 1.7× 19 247
Solange Oliveira Rodrigues Valle Brazil 11 170 0.8× 123 0.9× 214 1.7× 63 0.7× 54 0.9× 48 343
F. Hacard France 8 108 0.5× 58 0.4× 47 0.4× 44 0.5× 93 1.6× 44 222
Maximilian Reinhardt Germany 10 115 0.5× 78 0.6× 38 0.3× 184 2.2× 136 2.3× 18 301
Vanessa Venning United Kingdom 7 130 0.6× 138 1.0× 100 0.8× 139 1.6× 97 1.6× 10 294
Ashley B. Crew United States 6 113 0.5× 104 0.8× 88 0.7× 17 0.2× 37 0.6× 23 200
Elena Pezzolo Italy 9 78 0.4× 33 0.3× 21 0.2× 148 1.7× 143 2.4× 21 293
Laura Calabrese Italy 14 70 0.3× 65 0.5× 17 0.1× 131 1.5× 229 3.8× 51 436
Rodica Olteanu Romania 8 207 0.9× 46 0.3× 17 0.1× 173 2.0× 41 0.7× 16 309
Daniel Soteres United States 9 81 0.4× 54 0.4× 168 1.3× 51 0.6× 14 0.2× 37 270

Countries citing papers authored by Faiz Kermani

Since Specialization
Citations

This map shows the geographic impact of Faiz Kermani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faiz Kermani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faiz Kermani more than expected).

Fields of papers citing papers by Faiz Kermani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faiz Kermani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faiz Kermani. The network helps show where Faiz Kermani may publish in the future.

Co-authorship network of co-authors of Faiz Kermani

This figure shows the co-authorship network connecting the top 25 collaborators of Faiz Kermani. A scholar is included among the top collaborators of Faiz Kermani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faiz Kermani. Faiz Kermani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Kermani, Faiz, et al.. (2016). Patient Compliance:Setting the Scene. 21–24.
3.
Kermani, Faiz, et al.. (2013). Potential implications of wider data transparency in medical communications. Medical Writing. 22(2). 128–130. 1 indexed citations
4.
Kermani, Faiz. (2009). An exploratory study of key opinion leadership management trends among European pharmaceutical companies. Journal of Medical Marketing Device Diagnostic and Pharmaceutical Marketing. 9(4). 291–300. 3 indexed citations
5.
Kermani, Faiz, et al.. (2007). China commits itself to biotech in healthcare. Drug Discovery Today. 12(13-14). 501–503. 2 indexed citations
6.
Kermani, Faiz, et al.. (2006). The promise of South African biotech. Drug Discovery Today. 11(21-22). 962–965. 4 indexed citations
7.
Kermani, Faiz. (2006). The Future of Generics in Brazil. Journal of Generic Medicines The Business Journal for the Generic Medicines Sector. 3(4). 287–294. 1 indexed citations
8.
Kermani, Faiz, et al.. (2006). The development of the South African biotech sector. Journal of Commercial Biotechnology. 12(2). 111–119. 3 indexed citations
9.
Kermani, Faiz, et al.. (2006). Health economic aspects of patient non-compliance. 23–40.
10.
Kermani, Faiz. (2006). Patient Compliance: Sweetening the Pill. 2 indexed citations
11.
Kermani, Faiz, et al.. (2005). Thinking ahead for effective clinical trials. 3 indexed citations
12.
Kermani, Faiz, et al.. (2004). Where will industry go to for its high-calibre staff?. Journal of Commercial Biotechnology. 11(1). 63–71. 1 indexed citations
13.
Kermani, Faiz. (2004). Generics Companies: Aspiring to Innovate. Journal of Generic Medicines The Business Journal for the Generic Medicines Sector. 1(4). 336–346. 3 indexed citations
14.
Kermani, Faiz, et al.. (2003). Current and future prospects for the global biotechnology industry. Journal of Commercial Biotechnology. 10(2). 154–161. 6 indexed citations
15.
Kermani, Faiz, et al.. (2003). Patent issues and future trends in drug development. Journal of Commercial Biotechnology. 9(4). 332–338. 7 indexed citations
16.
Kermani, Faiz, Melanie S. Flint, & Sharon A.M. Hotchkiss. (2000). Induction and Localization of Cutaneous Interleukin-1β mRNA during Contact Sensitization. Toxicology and Applied Pharmacology. 169(3). 231–237. 20 indexed citations
17.
Kermani, Faiz. (2000). From Quackery to Credibility – Unconventional Healthcare in the Era of High-Tech Medicine. Journal of Medical Marketing Device Diagnostic and Pharmaceutical Marketing. 1(1). 90–91. 1 indexed citations
18.
Simpkin, James, Faiz Kermani, Juan S. Campa, et al.. (1999). Effects of corticotrophin releasing hormone on contractile activity of myometrium from pregnant women. BJOG An International Journal of Obstetrics & Gynaecology. 106(5). 439–445. 20 indexed citations
19.
Francis, David M., Faiz Kermani, B. F. O’Donnell, et al.. (1996). Dermal Mast Cell Activation by Autoantibodies Against the High Affinity IgE Receptor in Chronic Urticaria. Journal of Investigative Dermatology. 106(5). 1001–1006. 232 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026